Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression
| dc.contributor.author | Stein, Gary S. | |
| dc.contributor.author | Lian, Jane B. | |
| dc.contributor.author | Van Wijnen, Andre J. | |
| dc.contributor.author | Stein, Janet L. | |
| dc.contributor.author | Montecino, Martin A. | |
| dc.contributor.author | Javed, Amjad | |
| dc.contributor.author | Zaidi, Sayyed K. | |
| dc.contributor.author | Young, Daniel W. | |
| dc.contributor.author | Choi, Je-Yong | |
| dc.contributor.author | Pockwinse, Shirwin M. | |
| dc.date | 2022-08-11T08:08:48.000 | |
| dc.date.accessioned | 2022-08-23T16:09:06Z | |
| dc.date.available | 2022-08-23T16:09:06Z | |
| dc.date.issued | 2004-05-25 | |
| dc.date.submitted | 2009-01-13 | |
| dc.identifier.citation | Oncogene. 2004 May 24;23(24):4315-29. <a href="http://dx.doi.org/10.1038/sj.onc.1207676">Link to article on publisher's site</a> | |
| dc.identifier.issn | 0950-9232 (Print) | |
| dc.identifier.doi | 10.1038/sj.onc.1207676 | |
| dc.identifier.pmid | 15156188 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/32612 | |
| dc.description.abstract | We present an overview of Runx involvement in regulatory mechanisms that are requisite for fidelity of bone cell growth and differentiation, as well as for skeletal homeostasis and the structural and functional integrity of skeletal tissue. Runx-mediated control is addressed from the perspective of support for biological parameters of skeletal gene expression. We review recent findings that are consistent with an active role for Runx proteins as scaffolds for integration, organization and combinatorial assembly of nucleic acids and regulatory factors within the three-dimensional context of nuclear architecture. | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=15156188&dopt=Abstract">Link to Article in PubMed</a> | |
| dc.relation.url | http://dx.doi.org/10.1038/sj.onc.1207676 | |
| dc.subject | Bone and Bones; Cell Differentiation; Cell Division; Core Binding Factor Alpha 1 Subunit; Core Binding Factor Alpha 2 Subunit; Core Binding Factor Alpha 3 Subunit; Core Binding Factor alpha Subunits; DNA-Binding Proteins; Gene Expression Regulation; Neoplasm Proteins; Proto-Oncogene Proteins; Transcription Factors | |
| dc.subject | Life Sciences | |
| dc.subject | Medicine and Health Sciences | |
| dc.title | Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Oncogene | |
| dc.source.volume | 23 | |
| dc.source.issue | 24 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/gsbs_sp/1174 | |
| dc.identifier.contextkey | 693081 | |
| html.description.abstract | <p>We present an overview of Runx involvement in regulatory mechanisms that are requisite for fidelity of bone cell growth and differentiation, as well as for skeletal homeostasis and the structural and functional integrity of skeletal tissue. Runx-mediated control is addressed from the perspective of support for biological parameters of skeletal gene expression. We review recent findings that are consistent with an active role for Runx proteins as scaffolds for integration, organization and combinatorial assembly of nucleic acids and regulatory factors within the three-dimensional context of nuclear architecture.</p> | |
| dc.identifier.submissionpath | gsbs_sp/1174 | |
| dc.contributor.department | Department of Cell Biology and Cancer Center | |
| dc.contributor.department | Graduate School of Biomedical Sciences | |
| dc.source.pages | 4315-29 |
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorptionThe contribution of osteoclasts to the process of bone loss in inflammatory arthritis has recently been demonstrated. Studies in osteoclast biology have led to the identification of factors responsible for the differentiation and activation of osteoclasts, the most important of which is the receptor activator of NF-kappa B ligand/osteoclast differentiation factor (RANKL/ODF), a tumor necrosis factor (TNF)-like protein. The RANKL/ODF receptor, receptor activator of NF-kappa B (RANK), is a TNF-receptor family member present on both osteoclast precursors and mature osteoclasts. Like other TNF-family receptors and the IL-1 receptor, RANK mediates its signal transduction via TNF receptor-associated factor (TRAF) proteins, suggesting that the signaling pathways activated by RANK and other inflammatory cytokines involved in osteoclast differentiation and activation are interconnected.
-
Novel functional interactions between Trk kinase and p75 neurotrophin receptor in neuroblastoma cellsTo understand the functional interactions between the TrkA and p75 nerve growth factor (NGF) receptors, we stably transfected LAN5 neuroblastoma cells with an expression vector for ET-R, a chimeric receptor with the extracellular domain of the epidermal growth factor receptor (EGFR), and the TrkA transmembrane and intracellular domains. EGF activated the ET-R kinase and induced partial differentiation. NGF, which can bind to endogenous p75, did not induce differentiation but enhanced the EGF-induced response, leading to differentiation of almost all cells. A mutated NGF, 3T-NGF, that binds to TrkA but not to p75 did not synergize with EGF. Enhancement of EGF-induced differentiation required at least nanomolar concentrations of NGF, consistent with the low-affinity p75 binding site. EGF may induce a limited number of neuronal cells because it also enhanced apoptosis. Both NGF and a caspase inhibitor reduced apoptosis and, thereby, enhanced differentiation. NGF seems to enhance survival through the phosphatidylinositol-3 kinase (PI3K) pathway. Consistent with this hypothesis, Akt, a downstream effector of the PI3K pathway, was hyperphosphorylated in the presence of EGF+NGF. These results demonstrate that TrkA kinase initiates differentiation, and p75 enhances differentiation by rescuing differentiating cells from apoptosis via the PI3K pathway. Even though both EGF and NGF are required for differentiation of LAN5/ET-R cells, only NGF is required for survival of the differentiated cells. In the absence of NGF, the cells die by an apoptotic mechanism, involving caspase-3. An anti-p75 antibody blocked the survival effect of NGF. Brain-derived neurotrophic factor also enhanced cell survival, indicating that in differentiated cells, NGF acts through the p75 receptor to prevent apoptosis.
-
Subcellular partitioning of transcription factors during osteoblast differentiation: developmental association of the AML/CBF alpha/PEBP2 alpha-related transcription factor-NMP-2 with the nuclear matrixThe subnuclear location of transcription factors may functionally contribute to the regulation of gene expression. Several classes of gene regulators associate with the nuclear matrix in a cell type, cell growth, or cell cycle related-manner. To understand control of nuclear matrix-transcription factor interactions during tissue development, we systematically analyzed the subnuclear partitioning of a panel of transcription factors (including NMP-1/YY-1, NMP-2/AML, AP-1, and SP-1) during osteoblast differentiation using biochemical fractionation and gel shift analyses. We show that nuclear matrix association of the tissue-specific AML transcription factor NMP-2, but not the ubiquitous transcription factor YY1, is developmentally upregulated during osteoblast differentiation. Moreover, we show that there are multiple AML isoforms in mature osteoblasts, consistent with the multiplicity of AML factors that are derived from different genes and alternatively spliced cDNAs. These AML isoforms include proteins derived from the AML-3 gene and partition between distinct subcellular compartments. We conclude that the selective partitioning of the YY1 and AML transcription factors with the nuclear matrix involves a discriminatory mechanism that targets different classes and specific isoforms of gene regulatory factors to the nuclear matrix at distinct developmental stages. Our results are consistent with a role for the nuclear matrix in regulating the expression of bone-tissue specific genes during development of the mature osteocytic phenotype.
